Happy to see such a nice overview of radiotherapy and studies led by him during Rick Haas’ Nina Axelrad lecture #CTOS2023. The Netherlands Cancer Institute

proud to present this poster at the international sarcoma conference CTOS Omico Australia NHMRC CTC GENOMIC PROFILING OF GYNAECOLOGICAL SARCOMAS: REPORT FROM THE AUSTRALIA-WIDE PRECISION ONCOLOGY PROGRAM cdmcd.co/vanvDq

The #ProgramCommittee of CTOS #CTOS2023. It’s been such a fun journey putting the programme together w/ an amazing team of individuals! We have 1 more day to go, but definitely not too early to thank Ashleigh Griffiths, Gladdy Lab, #MaureenO’Sullivan as well as Jennifer & Barbara

High quality data (as always from ⁦Dario Callegaro⁩) quantifying the benefit of surgery in high volume centre (13 cases per year) - distance from black line to red/blue line shows magnitude of benefit. #ctos23

Really happy to see Mandy Ballinger receive the 2023 Liddy Shriver Early Research Award for her pioneering work over more than 15 years in sarcoma genetics and early detection to protect people with Li Fraumeni Syndrome. Garvan Institute of Medical Research UNSW Medicine & Health Omico Australia

Congrats ⁦Mandy Ballinger⁩ on your amazing work deservedly recognized with the Liddy Shriver award #ctos23. Has been great to see this work grow in impact over the years.

Liddy shriver award presentation by 🇦🇺 Mandy Ballinger at #CTOS2023 Incredible work & presentation 🤩 👏 #ISKS -> Genetic predisposition in #sarcoma -> #SMOC surveillance study -> clinical risk guidelines -> public 🇦🇺 funding for whole body MRI What next 👇 UNSW

Thank you Liz Connolly, looking forward to working with you more

Today, on #WorldCancerDay, we acknowledge people who have a cancer diagnosis & their families, & the challenges that come with this. Our appreciation also goes to every patient advocate, researcher & health care professional who are helping improve treatment & care.

Patient organisations took a consensus statement to @MarkButler last week calling for life-saving cancer drugs to be made urgently available to thousands more Aussies. Read it here: bit.ly/3VGrVsa

We are excited to have APOS 24 featured on #MedNews. 'Professor David Thomas wants to solve a problem. Australian cancer patients are waiting years to get access to new medicines through the PBS after they are approved by the TGA... Read more: mednews.com.au/omicos-thomas-…

We are thrilled share that over 5000 patients have been referred to PrOSPeCT*, by over 750 clinicians! For more information on Omico and PRoSPeCT, click here omico.com.au/news/4073/ #CancerMeetsItsMatch #PrecisionOncology #ClinicalTrials

Marking #RareCancers Awareness Day - Omico’s Professor David Thomas' Address will address the National Press Club Wednesday, 26 June at 12:30pm (AEST)! You can watch the broadcast live on the ABC TV Network. Info: npc.org.au/speaker/2024/1… Rare Cancers Australia #PrecisionOncology

Vale Chris Fletcher: brilliant, kind, courageous man. Thank goodness I met him. brighamandwomens.org/pathology/in-m…

This is massive news. Huge thanks to Dr Jane Tiller and the team, but particularly the families who shared their stories countless times to give the lived experience. 👏👏👏👏👏

Professor David Thomas is the 2024 Outstanding Cancer Researcher of the Year, recognised for a career driving breakthroughs and innovation not just in NSW, but globally. Congratulations, Prof Thomas! #cancerNSWawards Garvan Institute of Medical Research

Prof Thomas is recognised for his leadership in the development of precision oncology in Australia, which has extended the lives of thousands of incurable cancer patients through the use of genomics. #cancerNSWawards Garvan Institute of Medical Research

⁦⁦Omico Australia⁩ very own ⁦Professor DM Thomas⁩, Cancer Institute NSW Cancer Researcher of the Year. We’re very proud

A proud moment for Omico Australia - Prof David Thomas, receiving NSW’s highest cancer accolade @ the Premier’s Awards, recognising his remarkable work in sarcoma research, genomics & precision oncology. Our sincere thanks for all you do for those living with sarcoma.

‼️ There are many unanswered questions, unmet needs & work to be done👇 A global expert consensus meeting 🌍 is being planned to help address these needs ✋Please get in touch if you work or research in this space & would like to be involved 4/4 CMRI Chris O’Brien Lifehouse Peter Mac Cancer Centre